Submission for OMB Review; Comment Request Information Program on the Genetic Testing Registry, 72424-72425 [2011-30286]
Download as PDF
<![CDATA[
72424
Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, email
paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443–
1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: National Sample
Survey of Nurse Practitioners (OMB No.
0915–xxxx)—[New]
The number of nurse practitioners
(NP) in the United States has been
growing rapidly over the past decade,
and continued growth is expected as the
annual number of graduates from NP
programs is at an all time high.
Furthermore, over the past 20 years,
financial and regulatory changes have
impacted the growth in NPs. The
expansion of health insurance under the
‘‘Patient Protection and Affordable Care
Act’’ (Pub. L. 111–148) will have an
impact on the demand for services. With
increasing numbers, NPs are poised to
play a critical role in the nation’s efforts
to expand access to health care services.
Despite the increasing number and
roles of NPs, unfortunately, there are
currently only limited, inconsistent data
available to policy makers and the
health care community. Accordingly, it
is difficult for these leaders to quantify
or fully understand the role of NPs in
the current (or future projected course of
the) health care system. In fact, it is
difficult to estimate with confidence the
number of NPs practicing in the U.S.
today.
The primary purpose of the Bureau of
Health Profession’s National Sample
Survey of Nurse Practitioners data
collection is to: (1) Improve estimates of
NPs providing services; (2) describe the
settings where NPs are working; (3)
identify the positions/roles in which
Number of
respondents
Instrument
NPs are working; (4) describe the
activities and services NPs are providing
in the healthcare workforce; (5)
determine the specialties in which NPs
are working; (6) explore NPs’
satisfaction with and perception of the
extent to which they are working to
their full scope of practice; and (7)
assess variations in practice settings,
positions, and practice patterns by
demographic and educational
characteristics.
The statutory provision that
authorizes this data collection is section
761(b) of the Public Health Service Act,
‘‘National Center for Health Care
Workforce Analysis,’’ which is codified
at 42 U.S.C. 294n(b). The information
obtained from this survey will
ultimately lead to more accurate and
complete national estimates of the
current NP supply as well as assist in
the development of more accurate NP
supply and demand projections.
The annual estimate of burden is as
follows:
Responses per
respondent
Total responses
Hours per
response
Total burden
hours
National Sample Survey of Nurse Practitioners ........
14,300
1
14,300
.33
4,719
Total ....................................................................
14,300
..........................
14,300
..........................
4,719
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to (202) 395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: November 17, 2011.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2011–30214 Filed 11–22–11; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on DSK5SPTVN1PROD with NOTICES
National Institutes of Health
Submission for OMB Review;
Comment Request Information
Program on the Genetic Testing
Registry
National Institutes of Health
(NIH), PHS, DHHS.
ACTION: Request for comments
AGENCY:
Under the provisions of
Section 3507(a) (1)(D) of the Paperwork
SUMMARY:
VerDate Mar<15>2010
17:03 Nov 22, 2011
Jkt 226001
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on July 27, 2011, (76 FR 44937)
and allowed 60 days for public
comment. Twelve public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Institutes of Health may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Proposed Collection: Title: The
Genetic Testing Registry; Type of
Information Collection Request: New
collection; Need and Use of Information
Collection: Laboratory tests for more
than 2,000 genetic conditions are
available; however, there is no
centralized public resource that
provides information about the
availability and scientific basis of these
tests.
Recognizing the importance of making
this information easily accessible to
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
health care providers, patients,
consumers, and others, NIH is
developing a voluntary registry of
genetic tests. The Genetic Testing
Registry (GTR) will provide a
centralized, online location for test
developers, manufacturers, and
researchers to submit detailed
information about genetic tests. The
overarching goal of the GTR is to
advance the public health and research
in the genetic basis of health and
disease. As such, the Registry will have
several key functions, including (1)
Encouraging providers of genetic tests to
enhance transparency by publicly
sharing information about the
availability and utility of their tests; (2)
providing an information resource for
the public, including health care
providers, patients, and researchers, to
locate laboratories that offer particular
tests; and (3) facilitating genetic and
genomic data-sharing for research and
new scientific discoveries.
Frequency of Response: The
information will be submitted
voluntarily on a non-repeating,
continual basis. Submitters will be
requested to update their test
information at least once every 12
months.
E:\FR\FM\23NON1.SGM
23NON1
Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices
Respondents: Submitters to the GTR
are expected to include clinical
laboratories, researchers, and entities
that report and interpret tests performed
elsewhere. The GTR is not limited to
U.S. respondents; it will also include
submissions from outside the United
States. Information will be collected and
managed using an online submission
system.
Estimate of Burden: Although
participation in the GTR is voluntary, in
order to participate, respondents must
provide information for a certain subset
of fields, identified as the ‘‘minimal
fields.’’ GTR includes 31 minimal fields
and 85 optional fields. Sixteen of the 31
minimal fields refer to contact data and
other information about the laboratory,
which the respondent completes only
once. These data will autopopulate new
72425
test records, leaving 15 minimal fields
that require completion. The GTR will
also support bulk submission as an XML
file or uploading subsets of information
from spreadsheets, which will
significantly reduce the burden for
laboratories that want to provide
information on multiple genetic tests.
The annualized cost to respondents is
estimated at $1,103.
ESTIMATES OF HOUR BURDEN
Estimated
number of
respondents
Type of
respondents
Estimated
number of
responses per
respondent
Average burden hours per
response
Estimated total
annual burden hours requested
770
12
Minimal Fields: 0.5 .........................
Optional Fields: 2.5 ........................
Minimal Fields: 4,620.
Optional Fields: 23,100.
Total .........................................
sroberts on DSK5SPTVN1PROD with NOTICES
Laboratory .......................................
Personnel ........................................
770
........................
3.0 ..................................................
27,720.
Request For Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to (202) 395–6974, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instrument, contact: Amy P.
Patterson, M.D., Associate Director for
Science Policy, NIH, by mail to the
Office of Biotechnology Activities, 6705
Rockledge Dr., Suite 750, Bethesda, MD
20892; telephone (301) 496–9838; fax
(301) 496–9839; or email
gtr@od.nih.gov; or refer to the GTR Web
site at https://oba.od.nih.gov/gtr/gtr.html.
VerDate Mar<15>2010
17:03 Nov 22, 2011
Jkt 226001
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
Dated: November 16, 2011.
Amy P. Patterson,
Associate Director for Science Policy, NIH.
[FR Doc. 2011–30286 Filed 11–22–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentablematerial,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Hemodialysis and
Markers of Heart Failure.
Date: December 5, 2011.
Time: 2 p.m. to 3 p.m.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Barbara A WoynarowskA,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 754, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
402–7172, woynarowskab@niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special; Emphasis Panel. HAPO Follow up
Studies.
Date:December 7, 2011.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7791,
goterrobinsonc@extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Ancillary Study to
the Hispanic Community Health Study.
Date: December 8, 2011.
Time: 4:30 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 76, Number 226 (Wednesday, November 23, 2011)]
[Notices]
[Pages 72424-72425]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-30286]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request Information Program on
the Genetic Testing Registry
AGENCY: National Institutes of Health (NIH), PHS, DHHS.
ACTION: Request for comments
-----------------------------------------------------------------------
SUMMARY: Under the provisions of Section 3507(a) (1)(D) of the
Paperwork Reduction Act of 1995, the National Institutes of Health
(NIH) has submitted to the Office of Management and Budget (OMB) a
request to review and approve the information collection listed below.
This proposed information collection was previously published in the
Federal Register on July 27, 2011, (76 FR 44937) and allowed 60 days
for public comment. Twelve public comments were received. The purpose
of this notice is to allow an additional 30 days for public comment.
The National Institutes of Health may not conduct or sponsor, and the
respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
Proposed Collection: Title: The Genetic Testing Registry; Type of
Information Collection Request: New collection; Need and Use of
Information Collection: Laboratory tests for more than 2,000 genetic
conditions are available; however, there is no centralized public
resource that provides information about the availability and
scientific basis of these tests.
Recognizing the importance of making this information easily
accessible to health care providers, patients, consumers, and others,
NIH is developing a voluntary registry of genetic tests. The Genetic
Testing Registry (GTR) will provide a centralized, online location for
test developers, manufacturers, and researchers to submit detailed
information about genetic tests. The overarching goal of the GTR is to
advance the public health and research in the genetic basis of health
and disease. As such, the Registry will have several key functions,
including (1) Encouraging providers of genetic tests to enhance
transparency by publicly sharing information about the availability and
utility of their tests; (2) providing an information resource for the
public, including health care providers, patients, and researchers, to
locate laboratories that offer particular tests; and (3) facilitating
genetic and genomic data-sharing for research and new scientific
discoveries.
Frequency of Response: The information will be submitted
voluntarily on a non-repeating, continual basis. Submitters will be
requested to update their test information at least once every 12
months.
[[Page 72425]]
Respondents: Submitters to the GTR are expected to include clinical
laboratories, researchers, and entities that report and interpret tests
performed elsewhere. The GTR is not limited to U.S. respondents; it
will also include submissions from outside the United States.
Information will be collected and managed using an online submission
system.
Estimate of Burden: Although participation in the GTR is voluntary,
in order to participate, respondents must provide information for a
certain subset of fields, identified as the ``minimal fields.'' GTR
includes 31 minimal fields and 85 optional fields. Sixteen of the 31
minimal fields refer to contact data and other information about the
laboratory, which the respondent completes only once. These data will
autopopulate new test records, leaving 15 minimal fields that require
completion. The GTR will also support bulk submission as an XML file or
uploading subsets of information from spreadsheets, which will
significantly reduce the burden for laboratories that want to provide
information on multiple genetic tests. The annualized cost to
respondents is estimated at $1,103.
Estimates of Hour Burden
----------------------------------------------------------------------------------------------------------------
Estimated
Estimated number of Average burden hours Estimated total
Type of respondents number of responses per per response annual burden hours
respondents respondent requested
----------------------------------------------------------------------------------------------------------------
Laboratory........................ 770 12 Minimal Fields: 0.5.. Minimal Fields:
Personnel......................... Optional Fields: 2.5. 4,620.
Optional Fields:
23,100.
-----------------------------------------------------------------------------
Total......................... 770 .............. 3.0.................. 27,720.
----------------------------------------------------------------------------------------------------------------
Request For Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Enhance the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to (202) 395-6974,
Attention: Desk Officer for NIH. To request more information on the
proposed project or to obtain a copy of the data collection plans and
instrument, contact: Amy P. Patterson, M.D., Associate Director for
Science Policy, NIH, by mail to the Office of Biotechnology Activities,
6705 Rockledge Dr., Suite 750, Bethesda, MD 20892; telephone (301) 496-
9838; fax (301) 496-9839; or email gtr@od.nih.gov; or refer to the GTR
Web site at https://oba.od.nih.gov/gtr/gtr.html.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
Dated: November 16, 2011.
Amy P. Patterson,
Associate Director for Science Policy, NIH.
[FR Doc. 2011-30286 Filed 11-22-11; 8:45 am]
BILLING CODE 4140-01-P
